CRYO CELL INTERNATIONAL INC
CCELdata completeness 100%16 fiscal years on fileCRYO CELL INTERNATIONAL INC earns about 50% on equity, far above its ~9% cost of capital, and has bought back 4% of its shares over 5 years — the marks of a durable business run for its owners. The estimate methods put fair value between $0.52 and $5.39 a share.Whether it’s worth owning at today’s price is the last question — and yours to answer, below.
| Figure | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|
| Revenue | $28.9M1 | $30.3M2 | $31.3M3 | $32M4 | $31.6M4 |
| Net income | $2.08M5 | $2.77M6 | −$9.52M7 | $402,0958 | −$2.43M8 |
| Operating cash flow | $7.93M9 | $8.57M10 | $8.92M11 | $6.01M12 | $5.48M12 |
| Capital expenditure | $1.83M13 | $12.2M14 | $6.84M15 | $2.4M16 | $230,47516 |
| Free cash flow (derived) | $6.09M9 | −$3.6M10 | $2.08M11 | $3.61M12 | $5.25M12 |
| Total debt | $1.9M17 | $8.73M18 | $8.6M19 | $8.48M20 | $8.35M20 |
| Cash & equivalents | $8.26M21 | $1.7M22 | $406,06723 | $560,96024 | $319,03124 |
| Diluted shares | 8.4M | 8.5M | 8.3M | 8.2M | 8.1M |
Superscripts are receipts. Each links to the SEC filing the number came from (full list at the bottom).
10 shares is a claim on −$23.06 of net worth that earned you −$3.01 and generated $6.5 of cash last year, against $10.35 of debt.
It earned about 50% on equity, year after year, against a ~9% cost of capital — the footprint of real pricing power. Competition usually drags returns like this back down; here it hasn't.
seeing a moat in the numbers →Share count is down 4% over 5 years — management has been buying back stock, quietly handing owners a bigger slice. Total debt has risen 340% over the same window.
reading capital allocation →Signals, not verdicts — read from the filings above. Numbers don’t prove a moat; they show its footprint. You decide.
The 3 estimate methods that apply put fair value between $0.52 and $5.39 a share. They rest on different assumptions, so where they diverge is the story.
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears10
- fcfGrowth0.0%
- fcfBase$3.61M
assumptions (10)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- terminalGrowth2.5%
- projectionYears5
- fcfGrowth0.0%
- fcfBase$3.61M
assumptions (8)
- riskFreeRate4.7%
- equityRiskPremium5.0%
- beta100.0%
- equityWeight85.0%
- costOfDebtSpread1.5%
- taxRate21.0%
- normalizedEarnings$402,095
- growthAssumed0.0%
Different models answer different questions — which to trust when →
| Bear | 0.0% | $5.39 |
| Base | 0.0% | $5.39 |
| Bull | 5.0% | $6.94 |
Bear/base/bull growth = 0% / filed history / history + 5pp. Type a price to see the return each case implies.
Default growth 0.0%= this company’s own filed history (median-to-median FCF CAGR, clamped 0–20%). Your adjustments are recorded anonymously. They become the “what do owners actually believe” dataset.
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (RevenueFromContractWithCustomerIncludingAssessedTax)
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (NetIncomeLoss)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (NetIncomeLoss)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (NetIncomeLoss)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (NetIncomeLoss)
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (NetCashProvidedByUsedInOperatingActivities)
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (PaymentsToAcquirePropertyPlantAndEquipment)
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (LongTermDebt)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (LongTermDebt)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (LongTermDebt)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (LongTermDebt)
- 10-K · period ending 2021-11-30 · accession 0000950170-23-005220 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2022-11-30 · accession 0000950170-24-022275 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2023-11-30 · accession 0000950170-25-030138 (CashAndCashEquivalentsAtCarryingValue)
- 10-K · period ending 2024-11-30 · accession 0001193125-26-083096 (CashAndCashEquivalentsAtCarryingValue)